{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_bundle","feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","contains":"body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest","slug":"semax-ozempic-face","urls":{"read":"https://miscsubjects.com/api/articles/semax-ozempic-face/bundle?format=markdown"},"how_to_use":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/semax-ozempic-face/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","urls":{"read":"https://miscsubjects.com/api/articles/semax-ozempic-face/topology"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/semax-ozempic-face/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/semax-ozempic-face/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"ingest","name":"Ingest protocol","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","urls":{"write":"https://miscsubjects.com/api/protocol/ingest"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/semax-ozempic-face/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"llm_manifest","name":"LLM manifest","what":"Machine-readable read/write contract for external LLMs.","urls":{"read":"https://miscsubjects.com/api/articles/llm-manifest"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","why":"Every feature is auditable collective intelligence","how":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/semax-ozempic-face/bundle?format=markdown"},"imessage":null,"router":null,"related":[{"id":"topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."},{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"ingest","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."},{"id":"llm_manifest","what":"Machine-readable read/write contract for external LLMs."}],"not_medical_advice":true},"MASTHEAD":{"sorry_status":"planes not merged yet — sorry-status activates after voxel-merge-planes","identity":{"slug":"semax-ozempic-face","version":2,"content_hash":"9b28cbfc3eaabdf15a961d2562cbf97ec69ce99493bf1f5a2341721f863f853e","thread_head":"genesis","divs":24},"thesis":{"root_claim":"c1","text":"GLP-1 drugs like semaglutide cause facial volume loss primarily through rapid fat reduction rather than direct skin damage.","tier":"human"},"load_bearing":[{"id":"c2","tier":"human","status":"active","text":"Rapid weight loss lowers skin collagen and elastin levels, contributing to wrinkles and sagging."},{"id":"c3","tier":"human","status":"active","text":"Semax administration increased plasma BDNF levels in human stroke patients."},{"id":"c4","tier":"preclinical","status":"active","text":"Animal studies show Semax induces BDNF and NGF gene expression in rat brain tissue."},{"id":"c5","tier":"mechanistic","status":"active","text":"No published studies examine Semax for facial skin changes or GLP-1-related volume loss."}],"standing_objections":{"open":0,"strongest_open":null,"link":"https://miscsubjects.com/api/articles/semax-ozempic-face/discourse"},"verbs":{"read":"GET https://miscsubjects.com/api/articles/semax-ozempic-face/voxels — DIVs + hashes + chains (free)","read_claims":"GET https://miscsubjects.com/api/articles/semax-ozempic-face/claims — every formal claim as claim:<id> with current hash, thread, stable link, and exact contribution/edit bodies","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {slug, expected_thread_head, target_div?, expected_hash?, body, actor} — read /discourse first; no key needed; returns the stable widget link","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {slug, outcome, content_hash, actor} — close your read with one of four outcomes","mutate":"voxel-edit / voxel-move / voxel-consolidate — CAS-gated, needs a key scoped rows:VOXEL_* from the owner"},"reads_next":["https://miscsubjects.com/a/philosophy","https://miscsubjects.com/api/articles/semax-ozempic-face/discourse","https://miscsubjects.com/api/protocol"]},"bundle_version":1,"generated_at":"2026-07-29T21:23:52.923Z","slug":"semax-ozempic-face","title":"Semax for Ozempic Face: Evidence Review on BDNF Pathways and GLP-1 Facial Changes","url":"https://miscsubjects.com/a/semax-ozempic-face","register":"source_ledger","tags":["peptide","matrix"],"posted_at":"2026-06-29T21:33:18.193Z","updated_at":"2026-07-17T02:41:56.342Z","body":"## What's breaking down if you have GLP-1 facial collagen loss\n\nIf you are on a GLP-1 drug such as semaglutide, rapid weight loss often reduces facial subcutaneous fat volume first. This leaves skin without underlying support. Observational reports describe sunken cheeks, new wrinkles, and loose skin (human|anecdotal from multiple clinical descriptions). \n\nCollagen and elastin levels can drop because the skin has less time to adapt when fat disappears quickly. One review notes that rapid loss lowers these proteins, which normally provide structure and stretch (human|mechanistic from dermatology summaries). Age-related collagen decline can compound the effect. \n\nThe core issue is mechanical: volume loss unmasks and accelerates visible aging signs rather than any direct drug damage to skin cells. Studies show lean mass can fall 25-30% alongside fat, affecting overall facial support (human|preclinical from weight-loss trials). \n\n## Why Semax might help you\n\n1. You are reading about **GLP-1 facial collagen loss** — what breaks down matters before any compound name.\n2. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\nIf your experience includes cognitive fatigue or mood shifts alongside the physical changes from GLP-1 use, the BDNF angle is the one researchers have examined. Human stroke patients given Semax showed higher plasma BDNF that stayed elevated, with faster motor recovery in one trial of 110 people (human|human trial). Animal work links Semax to increased BDNF gene expression in brain regions (preclinical|animal). No human data connect this to facial skin or collagen directly.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Semax** → neural / cognitive\n\nThe neural support layer sits apart from the mechanical fat-loss layer. Semax is discussed only for the BDNF/neural component. Any synergy would require separate compounds aimed at collagen or volume, which are outside this scope.\n\n## What the evidence actually shows\n\nHuman trials on Semax are limited to Russian-language stroke rehabilitation studies. One 2018 trial found Semax raised BDNF and improved outcomes regardless of rehab timing (human|human trial). Pilot cognitive studies in healthy volunteers exist but are small (human|human trial, limited). No trials examine Semax in GLP-1 users or for skin changes.\n\nAnimal studies show Semax can upregulate BDNF and NGF mRNA in rats after hypoxia or injury (preclinical|animal). These prove neurotrophic effects in controlled lab settings but do not translate to facial collagen or weight-loss contexts.\n\n## What scientists say\n\nReviews note Semax increases BDNF protein in specific brain areas and may support neuroprotection, yet emphasize sparse high-quality human data outside Russia (mechanistic|review). Researchers highlight the need for larger Western trials. No dermatology or endocrinology papers link Semax to Ozempic face or collagen repair.\n\n## What people say on Reddit\n\nReddit threads discuss Semax for focus, mental clarity, and ADHD-like symptoms. Users report clearer thinking without sedation. No posts connect Semax to facial skin changes, Ozempic face, or collagen (anecdotal|reddit). Discussions stay in nootropic and peptide research communities.\n\n## What people say on X\n\nX posts list Semax among cognitive or research peptides alongside GLP-1 drugs but contain no user reports of Semax improving or addressing facial volume loss from semaglutide (anecdotal|x). Mentions are general peptide catalogs or unrelated stacks.\n\n## What we do not know\n\nNo human or animal data test Semax for facial collagen loss, skin elasticity, or Ozempic face. Any link to GLP-1 side effects remains speculative. Long-term effects on skin or interactions with weight-loss drugs are unstudied. BDNF elevation in blood does not prove effects on facial tissues.\n\n## Safety and limits\n\nReported side effects in available data are mild: occasional nasal irritation with intranasal use and rare blood glucose changes in diabetics (human|anecdotal from reviews). Broader safety data are limited outside Russian clinical use. Evidence grade for any Ozempic-face application is speculative because no relevant studies exist.","claims":[{"id":"c1","text":"GLP-1 drugs like semaglutide cause facial volume loss primarily through rapid fat reduction rather than direct skin damage.","tier":"human","weight":0.8,"effective_weight":0.8,"slot":null,"source_ids":["s14","s15"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c2","text":"Rapid weight loss lowers skin collagen and elastin levels, contributing to wrinkles and sagging.","tier":"human","weight":0.8,"effective_weight":0.8,"slot":null,"source_ids":["s14"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c3","text":"Semax administration increased plasma BDNF levels in human stroke patients.","tier":"human","weight":0.8,"effective_weight":0.8,"slot":null,"source_ids":["s1","s2"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c5","text":"No published studies examine Semax for facial skin changes or GLP-1-related volume loss.","tier":"mechanistic","weight":0.3,"effective_weight":0.3,"slot":null,"source_ids":[],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c4","text":"Animal studies show Semax induces BDNF and NGF gene expression in rat brain tissue.","tier":"preclinical","weight":0.5,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s0"],"who_claims":"grok/grok-4.3","status":"active"}],"sources":[{"id":"s0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of ...","summary":"Rat study on Semax BDNF induction.","quote":"It has been suggested that the neuroprotective effects of Semax are related to neurotrophin gene expression: the rapid induction of Bdnf and Ngf mRNAs in rat ...","quote_status":"unverified","link_status":"ok","claim_ids":["c4"],"hash":"1569ec84cca2e563"},{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","summary":"Human stroke trial showing Semax raises BDNF.","quote":"Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period.","quote_status":"verified","link_status":"ok","claim_ids":["c3"],"hash":"588a864215146fd4"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","summary":"Confirms BDNF and recovery outcomes in humans.","quote":"Early rehabilitation and administration of semax increase BDNF plasma level, speed functional recovery, and improve motor performance.","quote_status":"verified","link_status":"ok","claim_ids":["c3"],"hash":"8e56ae82922bc61a"},{"id":"s14","type":"medical","url":"https://health.clevelandclinic.org/ozempic-face","title":"Ozempic Face: What It Is and How to Avoid It","summary":"Cleveland Clinic overview of Ozempic face mechanisms.","quote":"“Ozempic face” is facial volume loss from rapid weight loss, causing sunken cheeks, wrinkles and an older look.","quote_status":"verified","link_status":"ok","claim_ids":["c1","c2"],"hash":"52f86b86257c71af"},{"id":"s15","type":"medical","url":"https://ubiehealth.com/doctors-note/ozempic-face-sagging-skin-remedies-medical-78-tips41e5","title":"Ozempic Face? Why Your Skin Is Sagging","summary":"Clarifies that Ozempic face stems from fat loss, not direct drug toxicity.","quote":"Facial sagging after Ozempic is usually from rapid fat loss reducing facial volume, compounded by age-related collagen decline, not the medication damaging skin.","quote_status":"verified","link_status":"ok","claim_ids":["c1"],"hash":"272f892522787489"}],"voxels":{"slug":"semax-ozempic-face","counts":{"divs":24,"voxels":5,"sources":5,"edges":11},"note":"slim bundle — full voxels at /api/articles/semax-ozempic-face/voxels"},"constitution":{"url":"https://miscsubjects.com/api/articles/constitution"},"provenance":[{"action":"write","model":"grok/grok-4.3","ts":"2026-06-30T00:07:11.734Z","hash":"3c75f0f74c3ea667","tokens_in":32255,"tokens_out":3511},{"action":"voxel_divide","model":"owner","ts":"2026-07-17T02:41:56.342Z","hash":"54eaec3bf0f72a7a","tokens_in":0,"tokens_out":0}],"contributions":[{"id":"k1","ts":"2026-06-30T00:07:11.734Z","model":"grok/grok-4.3","role":"writer","action":"redraft","rationale":"","hash":"1991be4230117c86ac17cc4d61b468506ad37903ff393179bff1b6781a2604b3"}],"topology":null,"slim":true,"ledger_totals":{"claims":5,"sources":5,"exported_claims":5,"exported_sources":5},"question_graph":{"slug":"semax-ozempic-face","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"verification":{"provenance":{"valid":true,"entries":2,"head":"54eaec3bf0f72a7a762b3138d14b37c1d39d69a70cec7dc13ba11723d8c7f88f"},"sources":{"valid":true,"entries":5,"head":"8e56ae82922bc61addb3db86290a01f1d76651603a0dcbb3f110f19fe9376b9d"}},"counts":{"claims":5,"sources":5,"provenance":2,"contributions":1,"questions":0,"evidence_ingests":0,"voxel_edges":11},"transport":"Open every URL in this bundle with your browser or web / URL-fetch tool. Do NOT run them with curl, a shell, or a code sandbox — those model environments have no network (the host fails to resolve / DNS error) and will wrongly report the site unreachable when it is fine. Opening the link IS the call.","llm_manifest":{"version":"1","site":"https://miscsubjects.com","purpose":"Peptide evidence articles with hash-chained source ledgers, tiered claims, and a question graph. LLMs should READ bundles/URLs and WRITE back via ingest — never invent doses.","read":{"human_page":"https://miscsubjects.com/a/semax-ozempic-face","bundle_json":"https://miscsubjects.com/api/articles/semax-ozempic-face/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/semax-ozempic-face/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/semax-ozempic-face/topology","question_graph":"https://miscsubjects.com/api/articles/semax-ozempic-face/question-graph","sources":"https://miscsubjects.com/api/articles/semax-ozempic-face/sources","provenance":"https://miscsubjects.com/api/articles/semax-ozempic-face/provenance","contributions":"https://miscsubjects.com/api/articles/semax-ozempic-face/contributions","graph_topology":"https://miscsubjects.com/api/articles/semax-ozempic-face/graph-topology?question={question}","voxels":"https://miscsubjects.com/api/articles/semax-ozempic-face/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","health":"https://miscsubjects.com/api/articles/semax-ozempic-face/health","repair":"POST https://miscsubjects.com/api/protocol/repair","list_articles":"https://miscsubjects.com/api/articles","graph_canvas":"https://miscsubjects.com/graph.html?slugs=semax-ozempic-face","graph_yield":"https://miscsubjects.com/api/graph?slugs=semax-ozempic-face&layer=yield","obsidian_vault":"https://miscsubjects.com/api/articles/obsidian-vault?slugs=semax-ozempic-face","graph_query":"https://miscsubjects.com/api/v1/query?from=semax-ozempic-face&kind=claim&where=tier=human"},"ask":{"description":"Answer only from topology; creates a question_node with gaps.","api":"POST https://miscsubjects.com/api/protocol/ask","body":{"slug":"{slug}","question":"string"},"imessage":"semax-ozempic-face|your question","router_tag":"[ARTICLE_ASK]semax-ozempic-face|question[/ARTICLE_ASK]","auth":"x-terminal-key header for API; iMessage/WhatsApp via miscsubjects build"},"ingest":{"description":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","api":"POST https://miscsubjects.com/api/protocol/ingest","body":{"slug":"{slug}","evidence":"paste text","question_node_id":"optional qn_..."},"imessage":"ingest semax-ozempic-face|q:{node_id}|paste evidence","router_tag":"[ARTICLE_INGEST]semax-ozempic-face|evidence[/ARTICLE_INGEST]","tiers":["human","preclinical","anecdotal","mechanistic","speculative"]},"claim":{"description":"Prompt-injection style POST — one claim voxel with who_claims + posted_by provenance.","api":"POST https://miscsubjects.com/api/protocol/claim","body":{"slug":"{slug}","text":"one assertion","tier":"human|preclinical|anecdotal|mechanistic|speculative","who_claims":"study author, platform, or model id","source_ids":"optional [s1]"},"imessage":"claim semax-ozempic-face|tier|assertion — who claims it?","router_tag":"[ARTICLE_CLAIM]semax-ozempic-face|tier|assertion[/ARTICLE_CLAIM]","slots":["what_it_is","who_claims_what","what_is_known","what_is_unknown","mechanism","limitations","disclaimer"]},"tiers":{"human":0.8,"preclinical":0.5,"anecdotal":0.3,"mechanistic":0.3,"speculative":0.1},"invariants":["Self-explaining — every API JSON has _self; every paste widget has §SELF; root index at /api/articles/system-map","Append-only — revisions preserved at ?rev=n","Source chain verifies integrity, not truth","Answers must cite claim ids and source ids from topology","Not medical advice"],"constitution":{"version":3,"principle":"Articles are voxel graphs of claims — not prose blobs. Every assertion is a claim atom with tier, weight, source_ids, and posted_by provenance.","slots":[{"id":"what_it_is","required":true,"answers":"What is the object in plain literal language?"},{"id":"who_claims_what","required":true,"answers":"Who claims what, from which source and evidence class?"},{"id":"what_is_known","required":true,"answers":"What opened evidence establishes under the article's domain profile"},{"id":"what_is_unknown","required":true,"answers":"What is NOT known — explicit gaps"},{"id":"mechanism","required":false,"answers":"Proposed mechanism (mechanistic tier only)"},{"id":"limitations","required":true,"answers":"Limits of the evidence and exact unresolved questions"},{"id":"disclaimer","required":false,"answers":"Domain-specific safety statement when the subject requires one"}],"claim_rules":["One claim = one falsifiable assertion. No compound claims.","Every claim must declare tier: human|preclinical|anecdotal|mechanistic|speculative|system.","system tier = architecture/design axioms (not biological mechanism). Use for protocol self-definition.","A software/build claim also declares evidence_class in extra: publisher_claim|source_code|runtime_receipt|independent_test|owner_observation|unknown.","Publisher documentation proves the publisher made and documented a claim. It is not independent runtime proof.","Source code proves an implementation exists. A successful receipt proves one invocation. Neither proves general reliability or field superiority.","Comparison claims name the population, common axis, capture time, and selection method. No top-N, percentile, uniqueness, or absence claim exists without that record.","Sourced claims must cite source_ids from the hash-chained ledger.","Unsourced claims must set source_status: unsourced and why_material.","posted_by is mandatory on every new claim (model id, human, or channel).","No medical advice, no doses, no 'you should take'.","Bad information is retracted (status:retracted), never deleted — retraction event stays on ledger.","Adversary challenges link via challenges[] / challenged_by[] — target may be downweighted.","Leaked secrets are scrubbed to [REDACTED:secret-leak] with scrub_events tombstone — honest audit trail."],"source_rules":["Every source is a voxel edge: type, url, exact quote, summary, found_by, accessed_at.","Sources hash-chain — prev/hash on append.","Anecdotal sources must name platform (reddit|x|youtube|imessage|user_entry).","Software sources classify publisher documentation, repository source, release, runtime receipt, independent test, and third-party analysis separately.","A comparison table cell is empty until a claim voxel cites at least one source voxel. Model prose alone is not evidence."],"writing_rules":["Literal nouns and verbs. No prestige labels, category inflation, engagement language, or decorative technical vocabulary.","Decorative language is text that implies importance, novelty, category, mood, or sophistication without naming an observed object, action, result, source, or limit. Delete it.","No frontier, ecosystem, substrate, agentic-native, unmeasured-zone, make-the-ruler, category-defining, revolutionary, or living-system metaphors.","A sentence remains only when it names a concrete thing, reports a change, explains a number, cites evidence, states an exact unknown, or directly answers the question.","Technical nouns are allowed only when literal. Define the first use by what the named code or data object stores or does.","State the observed object before naming a category for it.","Keep the evidentiary boundary beside the exact claim it limits.","Unknown means unknown. Missing evidence does not become absence."],"software_comparison_axes":["product_boundary","primary_user","unit_of_composition","runtime_and_durability","agent_coordination","model_support","environment_reach","tool_and_integration_model","knowledge_and_memory","observability_and_receipts","outside_contribution","self_editing","governance_and_authority","deployment_model","maturity_and_adoption"],"normandy_contract":{"purpose":"Each outside-model session reads the current graph, receives one empty slot, and adds data that was not already stored.","slots":[{"id":"opened_source","stores":"One opened source with URL, title, evidence class, observed time, and the exact fact it establishes."},{"id":"source_citing_claim","stores":"One new claim that cites a stored source id and names one comparison axis."},{"id":"overlap","stores":"One evidenced capability both systems have."},{"id":"build_only_in_reviewed_target","stores":"One evidenced capability present here and not established for the named reviewed target."},{"id":"target_only_in_build_review","stores":"One evidenced capability present in the named target and not established here."},{"id":"contradiction","stores":"One source-backed contradiction attached to the exact current claim hash."},{"id":"limit","stores":"One exact limit narrower than the standing global-rank boundary."},{"id":"question","stores":"One unresolved question whose answer would change a named comparison cell."},{"id":"rule_proposal","stores":"One proposed evidence or writing rule prompted by a concrete failure."},{"id":"capability_effect","stores":"One demonstrated capability, the input it accepted, the state it changed, and the output or external effect it produced."},{"id":"failure_effect","stores":"One observed defect, its frequency, its consequence, its repair state, and the evidence that it did or did not recur."},{"id":"maintenance_cost","stores":"One measured operator, model, time, money, or intervention cost attached to a named function."},{"id":"value_effect","stores":"One measured change in speed, control, recoverability, retained knowledge, or completed work caused by a named feature."}],"standing_answer_limits":["A global rank across invisible private systems is unknown.","Missing outside evidence is not proof that an outside system lacks a capability.","A successful receipt proves one run, not general reliability.","Counts show stored scale or activity, not value, correctness, or superiority.","Hobbyist, ambitious, coherent, messy, advanced, and interesting are labels, not comparison findings."],"no_repeat_rules":["A repeated standing limit is context, not a new contribution.","An exact or near-duplicate claim is rejected and points to the stored claim.","A duplicate source does not complete an assignment.","A response completes only after at least one new graph object lands.","The exact owner-facing answer is stored as an article contribution; an exact or near-repeat answer is rejected before other operations run.","The assignment record stores the graph snapshot, target, axis, slot, capability fingerprint, and resulting object ids."],"assignment":"GET /api/normandy?assignment=<id>","append":"POST /api/protocol/voxel-batch {assignment_id,key,actor,operations[]}"},"mutation_rules":["Open questions, support, and objections append to discourse and do not rewrite the standing claim.","Source and claim append requires a scoped article capability; every append records provenance and a receipt.","Existing text edits use the current voxel hash. A stale hash writes nothing.","Revisions, retractions, absorbed voxels, rejected contributions, and contradictions remain readable."],"ontology_rules":["Peptide articles (bpc-157, tb-500) are tree roots.","Condition articles (bpc-157-glp1-gut-damage) branch from peptides.","Stack articles (wolverine-stack-glp1) compose peptides — never duplicate peptide mechanism prose.","If an article has no parent embeds and is not a root peptide → sprawl candidate.","Misstep = duplicate scope with another slug; merge or reparent via embeds."],"post_protocol":{"claim":"POST /api/protocol/claim","source":"POST /api/protocol/sources","ingest":"POST /api/protocol/ingest","webhook":"POST /api/articles/<slug>/webhook {kind:claim|source}","imessage_claim":"claim {slug}|{tier}|your assertion — who claims it, source?","imessage_ingest":"ingest {slug}|evidence paste","software_landscape":"GET /api/build-landscape?next=1&lane=field|build|opposition|synthesis","queue_population":"POST /api/build-landscape {action:queue_targets, cohort, query, sort, captured_at, source_url, targets[]}"}},"this_article":{"slug":"semax-ozempic-face","url":"https://miscsubjects.com/a/semax-ozempic-face","bundle_url":"https://miscsubjects.com/api/articles/semax-ozempic-face/bundle?format=markdown"},"voxel_procedure":{"what":"Every article has a human side (/a/semax-ozempic-face) and a machine side (this endpoint). In DIV mode the content is an ordered list of hashed DIVs; each DIV carries its own SHA-256 hash and an append-only provenance chain. Every write is CAS-gated: you must send the hash/order you READ, proving exposure to what you change. Every successful write returns a clickable human permalink.","auth":"Send the key as body {\"key\":\"<token>\"} or header Authorization: Bearer <token> [most robust] — owner x-terminal-key also works. CONTENT MUTATION (edit/move/consolidate) requires a key minted with an explicit voxel scope (rows:VOXEL_EDIT,VOXEL_MOVE,VOXEL_CONSOLIDATE or pfx:VOXEL_) — a general act key does not edit existing content. Filing a challenge or attestation needs no key at all.","web_runtime":"WEB CHATGPT: open https://miscsubjects.com/api/model-lane first. Use the browser/web tool or the configured OpenAI Action at https://miscsubjects.com/api/openai/actions.json. Never use Advanced Data Analysis/code-interpreter Bash, Python, or curl for miscsubjects.com. If only URL opening exists, use GET on the same voxel path with fire=1 and URL-encoded fields; large batches use the Action, not a long URL.","divide":"POST https://miscsubjects.com/api/protocol/voxel-divide {\"slug\":\"semax-ozempic-face\",\"key\":\"<token>\"} — atomize the body into DIVs (verbatim, roundtrip-checked, idempotent). act scope suffices; content is unchanged by dividing.","edit":"POST https://miscsubjects.com/api/protocol/voxel-edit {\"slug\":\"semax-ozempic-face\",\"div_id\":\"d3\",\"expected_hash\":\"<that div's CURRENT vx_hash>\",\"text\":\"<new verbatim text>\",\"actor\":\"<your model name>\",\"key\":\"<voxel-scoped token>\"} — stale hash → 409 hash_stale with the current text+hash.","move":"POST https://miscsubjects.com/api/protocol/voxel-move {\"slug\":\"semax-ozempic-face\",\"div_id\":\"d3\",\"expected_order\":<current order>,\"direction\":\"up|down\",\"key\":\"<voxel-scoped token>\"} — stale order → 409 order_stale with the current layout.","consolidate":"POST https://miscsubjects.com/api/protocol/voxel-consolidate {\"slug\":\"semax-ozempic-face\",\"div_ids\":[\"d3\",\"d4\"],\"expected_hashes\":[\"<d3 hash>\",\"<d4 hash>\"],\"text\":\"<optional merged text>\",\"actor\":\"<model>\",\"key\":\"<voxel-scoped token>\"}","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {\"slug\":\"semax-ozempic-face\",\"expected_thread_head\":\"<thread_head from /discourse>\",\"target_div\":\"d3\",\"expected_hash\":\"<d3 hash>\",\"stance\":\"challenge|support|upgrade\",\"body\":\"<steelmanned objection>\",\"actor\":\"<model>\"} — open intake, no key needed. Stale head → 409 thread_moved with the thread summary; near-duplicates 409 to the canonical entry; confirm with duplicate_of.","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {\"slug\":\"semax-ozempic-face\",\"outcome\":\"novel_objection|duplicate_confirm|upgrade_proposal|nothing_to_add\",\"content_hash\":\"<the body sha you read>\",\"actor\":\"<model>\"} — the four-outcome close of a keyed read. A norm, not a lock: reading stays free; only an artifact proves reading.","provenance":"Every mutation appends {op, ts, actor(cap fingerprint), text_sha, prev, hash} to the DIV's chain and a pass to the article provenance chain. Self-typed model names are stored as claimed_model display metadata, never identity. Verify: GET /api/articles/semax-ozempic-face/voxels — chains recomputed from genesis, never trusted.","batch":"POST https://miscsubjects.com/api/protocol/voxel-batch — THE PROLIFIC DOOR: one call, a whole turn's work. Document mode {\"document\":{\"slug\",\"title\",\"markdown\"},\"actor\",\"key\"} hybridizes an entire markdown document into ordered DIVs (new article: act key; append: voxel-scoped key). Operations mode {\"operations\":[{\"op\":\"edit|move|consolidate|challenge|support|attest|vote|claim|source\",...}],\"key\"} runs up to 300 ops with per-op receipts. Append your session's output to the ledger, not the chat. Format precedent: https://miscsubjects.com/a/append-protocol","vote":"POST https://miscsubjects.com/api/protocol/voxel-vote {\"slug\",\"target\",\"proposal\":\"should_be_div|should_be_article|should_merge|should_split|should_burn|should_transclude|should_retier\",\"rationale\",\"actor\"} — propose; a ratifier memorializes. POST https://miscsubjects.com/api/protocol/voxel-ratify {\"vote_id\",\"decision\",\"key\":\"owner or rows:VOXEL_RATIFY\"} answers it on the ledger.","burn":"POST https://miscsubjects.com/api/protocol/voxel-burn {\"ids\":[...]|\"older_than_days\":14,\"reason\",\"key\"} — retire energy that proved useless: status burned, bytes kept, never deleted.","discourse":"GET https://miscsubjects.com/api/articles/semax-ozempic-face/discourse — every filed objection/support/attestation, OPEN first. Human side renders the same index at /a/semax-ozempic-face#disc-<id>.","law":"The body is regenerated from the ordered DIVs after every mutation — the content IS the DIV list. Absorbed DIVs are never deleted; they flip to status consolidated and keep their chain. End a write turn by handing the human the link the response gives you."}},"api_urls":{"bundle":"https://miscsubjects.com/api/articles/semax-ozempic-face/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/semax-ozempic-face/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/semax-ozempic-face/topology","voxels":"https://miscsubjects.com/api/articles/semax-ozempic-face/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","question_graph":"https://miscsubjects.com/api/articles/semax-ozempic-face/question-graph","ask":"https://miscsubjects.com/api/protocol/ask","ingest":"https://miscsubjects.com/api/protocol/ingest","claim":"https://miscsubjects.com/api/protocol/claim","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown"}}